Blogg

  • Reset
10.16.23 | Policy
SWHR Joins American Heart Association, Partners on Letter Thanking Sponsors of National Cholesterol Education Month Resolution

 7.26.23 | Policy
SWHR Thanks Women’s Caucus for Calling for Women’s Heart Health Prioritization

 7.10.23 | Policy
SWHR Submits Comments to ICER on Proposed 2024 Value Assessment Framework

 3.31.23 | Autoimmune
Federal Agencies’ Work in Autoimmune Diseases and Conditions

The U.S. government—through its programs and initiatives—has an important role to play in improving the lives of those living with […]

 3.31.23 | Autoimmune
The Need for Diversity in Autoimmune Disease Research Trials

While the United States has made progress to close the gaps that have resulted from the historical exclusion of women […]

 3.27.23 | Policy
SWHR Submits FY24 Outside Witness Testimony to LHHS Appropriations Subcommittee

 3.13.23 | Autoimmune
Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions

Autoimmune diseases are estimated to affect anywhere between 23.5 and 50 million Americans, and recent evidence has shown that the […]

 2.10.23 | Autoimmune
Issues Affecting Health Care Coverage and Access for Women with Autoimmune Diseases and Conditions

Autoimmune diseases and conditions, a group of more than 80 chronic and often disabling diseases that develop when the immune […]

 2.7.23 | Policy
SWHR Provides Feedback to ICER on Draft Evidence Report on Treatments for Alzheimer’s Disease

 1.30.23 | Policy
SWHR Responds to RFI on Clinical Research Infrastructure and Emergency Clinical Trials